ReviewFrontiers in oncology2017

Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors.

Andrea Morandi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.